SlideShare a Scribd company logo
1 of 50
PRESENTATION
ON
IMMUNIZATION
PRESENTED TO: PRESENTED BY:
Miss Manisha Sehgal
Assistant Professor
ACN
Miss Muskan Thakur
BS22MHNS007
MSc. Nursing 1st Year
INTRODUCTION
 Immunization is the process of artificially
inducing immunity or providing protection from
disease.
 Immunization is the artificial means by which
the state of immunity is increased.
 This is the most important invention that
conferred the highest benefit to children in the
world.
 It has helped eradicate polio and small pox for
the community.
DEFINITION
 “Immunization is a process of protecting an individual
from a disease through introduction of live or killed or
attenuated organisms in the individual system to create
immunity.”
SIGNIFICANCE
 It is most cost-effective health interventions in reduction
of communicable diseases related morbidity and mortality.
 It is a mass means of protecting the largest number of
people from various diseases.
 It gives resistance to an infectious disease by producing
or augmenting the immunity.
 Artificially acquired immunity is developed by
immunization.
IMMUNITY
 Immunity is the security against a particular disease and
nonsusceptibility to the invasive or pathogenic effects of
foreign microorganisms or to the toxic effect of antigenic
substances.
 Acquired immunity can be
1. Active -vaccines
2. Passive- immunoglobulins
TYPES OF IMMUNIZATION
 Active immunization:
 It is the process of stimulating the body to
produce antibody and other immune responses
through administration of a vaccine or toxoid.
 Passive Immunization:
 Passive immunization is provision of temporary
immunity by administration of preformed
antibodies derived from humans or animals.
PROCESS OF GENERATION OF IMMUNITY
AFTER VACCINATION:
1. PRIMARY RESPONSE:
 When an antigen is administered for the first time to an
animal or human who has never been exposed to it, there is
a latent period of induction of 3 to 10 days before
antibodies appear in the blood.
2. SECONDARY (BOOSTER) RESPONSE:
 The response to a booster dose differs in a number of ways
from the primary response. Production of antibody is more
rapid. Antibody response maintained at higher levels for a
longer period of time.
VACCINE:
 Term derived from “vaccae=cow”. So, immunization agent
is known as vaccine. Vaccine is a immuno- biological
substance designed to produce specific protection against a
given disease.
Types of vaccine
MILSTONE IN VACCINATION:
 1798 - Smallpox vaccine
 1885 - Rabies vaccine
 1921 - BCG
 1927 - Tetanus toxoid
 1954 - Salk's Polio vaccine
 1957 - Sabin live oral Polio vaccine
 1960 - Measles vaccine
 1962 - Rubella vaccine
 1980- smallpox declared eradicated from the world.
EXPANDED PROGRAM ON IMMUNISATION:
 WHO launch a global immunization program, known as
Expanded Program on Immunization (EPI) in May 1974.
 To protect all children of the world against six vaccine-
preventable diseases, namely - diphtheria, whooping cough,
tetanus, polio, tuberculosis and measles by the year 2000.
 EPI was launched in India in January 1978.
UNIVERSAL IMMUNISATION PROGRAMME:
 The Indian version, the Universal Immunization Program,
was launched on November 19, 1985.
 The National Health Policy aimed at achieving universal
immunization coverage of the eligible population by 1990.
NATIONAL IMMUNISATION SCHEDULE:
VACCINE WHEN TO GIVE DOSE ROUTE SITE
FOR INFANTS
BCG At birth (or as early
as possible till one
year of age)
0.05ml
(0.1ml
after 1
month
till 1
year of
age)
I/D Left upper arm
Hepatitis B At birth (or as early
as possible within 24
hours)
0.5ml I/M Antero-lateral
side of mid-
thigh
OPV-0 At birth (or as early
as possible within
the first 15 days)
2 drops Oral
Cont…
VACCINE WHEN TO GIVE DOSE ROUTE SITE
OPV-1,2&3 At 6 weeks, 10 weeks
&14 weeks (can be
given till 5 years of
age)
2 drops Oral
Rota Virus-
1,2&3
At 6 weeks, 10 weeks
&14 weeks (can be
given till one year of
age)
5 drops Oral
Pentavalent
1,2&3
At 6 weeks, 10 weeks
&14 weeks (can be
given till one year of
age)
0.5ml I/M Antero-lateral
aspect of mid-
thigh (LEFT)
Cont…
VACCINE WHEN TO GIVE DOSE ROUTE SITE
IPV Two fractional
doses at 6 weeks
&14 weeks
0.1ml I/D Right upper arm
Measles and
Rubella-1
9 completed months
– 12 months (given
up to 5 years if not
received at 9-
12month age)
0.5ml S/C Right upper arm
Japanese
Encephalitis-1
9 completed months
-12months
0.5ml S/C Left upper arm
Vitamin A (1st
dose)
At 9 months with
measles - Rubella
1ml Oral
Cont…
FOR CHILDREN
VACCINE WHEN TO GIVE DOSE ROUTE SITE
DPT booster-
1
16-24 month 0.5 ml I/M Anterolateral
aspect of mid-
thigh
Measles and
Rubella-2
16-24 month 0.5 ml S/C Right upper arm
OPV booster 16-24 month 2 drops Oral
Japanese
Encephalitis-
2
16-24 month 0.5 ml S/C Left upper arm
Cont…
VACCINE WHEN TO GIVE DOSE ROUTE SITE
Vitamin A
(2nd to 9th
dose)
16 months with
DPT/OPV booster.
Then one dose every
6 month up to the
age of 5 years
2 ml Oral
DPT
booster-2
5-6 years 0.5 ml I/M Upper Arm
TT 10 years & 16 years 0.5 ml I/M Upper Arm
Cont…
FOR PREGNANT WOMEN
VACCINE WHEN TO GIVE DOSE ROUTE SITE
TT-1 Early in pregnancy 0.5ml I/M Upper Arm
TT-2 4 weeks after TT-1 0.5ml I/M Upper Arm
TT-booster If received 2 TT
doses in a pregnancy
within the last 3 years
0.5ml I/M Upper Arm
IAP SCHEDULE:
AGE VACCINE
Birth BCG
OPV (zero dose)
Hep B-1
6 weeks Hep B-2
IPV-1
DPT-1
Hib-1
PCV (Pneumococcal conjugate)-1
Rotavirus-1
10 weeks Hep B-3
IPV-2
DPT-2
Hib-2
PCV-2
Rotavirus-2
Cont…
AGE VACCINE
14 weeks Hep B-4
IPV-3
DPT-3
Hib-3
PCV-3
Rotavirus-3
6 months Influenza-1
7 months Influenza-2
6-9 months TCV (Typhoid Conjugate
Vaccine)
9 months MMR-1,
Cont…
AGE VACCINE
15 months MMR-2
Varicella-1
PCV booster
16-18 months IPV booster-1
DPT booster-1
Hib booster-1
18-24 months Hep A-2
Varicella-2
4-6 years IPV booster-1
DPT booster-2
MMR-3
9-14 years Tdap
HPV-1&2
15-18 years HPV-1,2&3
Passive immunization in VPD:
Passive immunization is applied in following vaccine
preventable disease:
 Diphtheria,
 Tetanus,
 Hepatitis B
 Rabies &
 Measles.
Vaccine Preventable diseases:
According to CDC:
 Chickenpox
 Diphtheria
 Flu
 Hepatitis A
 Hepatitis B
 Hib
 Measles
 Meningococcal
 Mumps
 Polio
 Pneumococcal
 Rotavirus
 Rubella
 Tetanus
 Whooping Cough
DIPTHERIAANTITIOXIN:
DOSE:
 Prophylactic: 500 to 2000 units by S/C or I/M injection;
 Therapeutic: 10,000 to 30,000 units by I/M injection or
40,000 to 100,000 units by I/V injection in 2 divided doses
with an interval of 12 to 24 hours.
MEASLES IMMUNOGLOBULIN (HUMAN):
DOSE-
 Recommended by WHO is 0.25 ml per kg of body weight.
It should be given within 3-4 days of exposure.
 The person passively immunized should be given live
measles vaccine 8-12 weeks later.
HEPATITIS B IMMUNOGLOBIN:
 The recommended dose is 0.05 to 0.07 ml/kg of body
weight;
 two doses should be given 30 days apart.
 HBIG provides short-term passive protection which lasts
approximately 3 months.
TETANUS IMMUNOGLOBIN:
Dose –
 250 unit for prophylaxis
 3000-6000 for therapeutic
HOW TO DESCRIBE A VACCINE:
Whenever one describes a vaccine, it must be done under the
following heads:
 Type
 Content
 Dose
 Time of administration
 No of doses including boosters.
Cont…
 Diluent if any
 Time after reconstitution
 Efficacy
 Storage
 Side effects
 contraindications
FOR EXAMPLE:
Measles vaccine:
 1. Type- Freeze dried vaccine contains live attenuated
virus; Stored at 2-8 degree C.
 2. Dose- 0.5 ml;
 3. Route- Subcutaneous.
 4. Time of administration- 9 months in India.
 According to W.H.O if child is malnourished,
 1st dose is b/w 6-8 months;
 2nd dose after 1 year.
Cont…
 5. Efficacy of Vaccine-
 95%if given after one year.
 At nine months -85%
 6. Duration of immunity– Lifelong.
 7. It is freeze dried vaccine
 8. Has to be reconstituted with distilled water
 9. Reconstituted vaccine must be used as early as possible
 10. It has shell life for 2 years
 11. Must be stored between 2-8 degree centigrade
Recent W.H.O. recommendation –
 1st dose of measles at 9 months.
 2nd dose of M.M.R. – 15 months.
 This vaccine may also be given to contacting person.
Complications of vaccine:
 1. Fever
 2. Rash
 4. T.S.S
Contraindications of Measles vaccine:
 1. Impaired cell-mediated immunity.
 2. Convulsions.
 3. Patient on steroids.
 4. Pregnancy
 5. Active T.B.
 6. Acute infectious disease.
 7. Generalized allergy.
How to calculate vaccine requirement:
There are two ways to calculate vaccine requirement—
 1. Based on real number of beneficiaries in community.
 2. Based on, Birth Rate and IMR.
Based on real number of beneficiaries in community.
 Count the total number of beneficiaries, like infant,
pregnant mother etc.
 Multiply it with total number of doses of vaccine to be
given.
 Now multiply it with wastage factor for different vaccines
 E.g.- If there are 100 infants. Number of doses of BCG
require will be:
 100× 1 × 1.33= 133 doses
 Since vial of BCG come in doses of 10.
 So needed vial will be= 133/10= 13.3 i.e., 14
RESEARCH ARTICLE
 Telemedicine in the National Immunization
Program (Brazil): A promising tool
 The objective of this study was to evaluate the acceptance and
impact of telemedicine at a Reference Center for Special
Immunobiological (CRIE). Patients aged 18 years or older who had
a medical referral to CRIE and agreed to have a telemedicine
consultation were included. From April 2021 to February 2022,
702 telemedicine consultation were conducted. Over 3,380
vaccines were prescribed via telemedicine. Of all the participants
who answered the satisfaction questionnaire, 99.8% stated that they
would recommend the service to other people.
SUMMARY
 In this topic I have explained about introduction, definition
& significance of immunization. Immunity and types of
immunity and immunization also explained. Process of
generation of immunity after vaccination, vaccine & types
of vaccine, milestones in immunization, expanded program
on immunization, universal immunization program,
national and IAP immunization schedule also discussed.
Passive immunization in VPD & how to describe a vaccine.
CONCLUSION
 Vaccines for contagious diseases have strong spillover
effects, given that immunization interrupts the disease
transmission process and reduces the likelihood that an
infection will harm others. Immunization helps protect
future generations by eradicating diseases.
 It is the process of the production of antibodies against
diseases. These are mainly used against bacterial and viral
diseases in both humans and cattle.
RECAPITULATION
 Define immunization?
 What is immunity?
 What are the types of immunization?
 Explain about national immunization program?
 What is passive immunization in VPD?
 How to describe a vaccine?
MCQ-
 1. Name the vaccine which was first discovered in the
world
 a) Rabies
 b) Plaque
 c) Small pox
 d) Chicken pox
Cont…
 2. In which year small pox vaccine was
discovered
 a) 1798
 b) 1898
 c) 1998
 d) 1800
Cont…
 3. The dose of immunoglobulin in the
prevention of measles is
 a) 1 ml/kg
 b) 1.5ml/kg
 c) 0.5ml/kg
 d) 0.25ml/kg
Cont…
4. Universal Immunization programme started in
India
a. 1974
b. 1978
c. 1985
d. 1995
Cont…
 5. Sabin is type of vaccine
a. Live
b. Killed
c. Toxoid
d. Killed
Cont…
 6. BCG vaccine must be used after dilution/
reconstitution within
a. 24 hours
b. 12 hours
c. 6 hours
d. 4 hours
ASSIGNMENT
 Make assignment on immunization schedule.
PRESENTATION ON IMMUNIZATION.pptx

More Related Content

What's hot

National immunization schedule 2016 (latest)
National immunization schedule 2016 (latest)National immunization schedule 2016 (latest)
National immunization schedule 2016 (latest)Dr. Saurabh Agrawal
 
Rubella (Seminar)
Rubella (Seminar)Rubella (Seminar)
Rubella (Seminar)Kunal Modak
 
National leprosy eradication programme (nlep)
National leprosy eradication programme (nlep)National leprosy eradication programme (nlep)
National leprosy eradication programme (nlep)Khemchand Sahu
 
Pulmonary TB (Tuberculosis) PPT SlideShare
Pulmonary TB  (Tuberculosis) PPT SlideSharePulmonary TB  (Tuberculosis) PPT SlideShare
Pulmonary TB (Tuberculosis) PPT SlideSharesonam
 
Communicable
CommunicableCommunicable
Communicableweak
 
National Aids Control Programme 1
National Aids Control Programme 1National Aids Control Programme 1
National Aids Control Programme 1Dinesh Ram
 
National leprosy eradication program
National leprosy eradication programNational leprosy eradication program
National leprosy eradication programswati shikha
 
Guidelines On The Prevention of Dengue fever
Guidelines On The Prevention of Dengue feverGuidelines On The Prevention of Dengue fever
Guidelines On The Prevention of Dengue feverJyoti Prasad Rout
 
Expanded program on immunization
Expanded program on immunizationExpanded program on immunization
Expanded program on immunizationNickFlare
 
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxWORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxanjalatchi
 
NATIONAL AIDS CONTROL PROGRAMME (NACP)
NATIONAL AIDS CONTROL PROGRAMME  (NACP)NATIONAL AIDS CONTROL PROGRAMME  (NACP)
NATIONAL AIDS CONTROL PROGRAMME (NACP)ManjeetKaur132
 
tuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxtuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxanjalatchi
 
national health programmes
national health programmesnational health programmes
national health programmesS.Bhakti swarupa
 
National Leprosy Eradication Program - Dr Surendran Venkataraman
National Leprosy Eradication Program - Dr Surendran VenkataramanNational Leprosy Eradication Program - Dr Surendran Venkataraman
National Leprosy Eradication Program - Dr Surendran VenkataramanSurendran Venkataraman
 

What's hot (20)

National immunization schedule 2016 (latest)
National immunization schedule 2016 (latest)National immunization schedule 2016 (latest)
National immunization schedule 2016 (latest)
 
Rubella (Seminar)
Rubella (Seminar)Rubella (Seminar)
Rubella (Seminar)
 
National leprosy eradication programme (nlep)
National leprosy eradication programme (nlep)National leprosy eradication programme (nlep)
National leprosy eradication programme (nlep)
 
Pulmonary TB (Tuberculosis) PPT SlideShare
Pulmonary TB  (Tuberculosis) PPT SlideSharePulmonary TB  (Tuberculosis) PPT SlideShare
Pulmonary TB (Tuberculosis) PPT SlideShare
 
Immunization schedule
Immunization  scheduleImmunization  schedule
Immunization schedule
 
Sexually Transmitted Diseases
Sexually Transmitted DiseasesSexually Transmitted Diseases
Sexually Transmitted Diseases
 
Communicable
CommunicableCommunicable
Communicable
 
National Aids Control Programme 1
National Aids Control Programme 1National Aids Control Programme 1
National Aids Control Programme 1
 
Tuberculosis TB
Tuberculosis TBTuberculosis TB
Tuberculosis TB
 
National leprosy eradication program
National leprosy eradication programNational leprosy eradication program
National leprosy eradication program
 
Guidelines On The Prevention of Dengue fever
Guidelines On The Prevention of Dengue feverGuidelines On The Prevention of Dengue fever
Guidelines On The Prevention of Dengue fever
 
Expanded program on immunization
Expanded program on immunizationExpanded program on immunization
Expanded program on immunization
 
Immunization
ImmunizationImmunization
Immunization
 
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxWORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
 
NATIONAL AIDS CONTROL PROGRAMME (NACP)
NATIONAL AIDS CONTROL PROGRAMME  (NACP)NATIONAL AIDS CONTROL PROGRAMME  (NACP)
NATIONAL AIDS CONTROL PROGRAMME (NACP)
 
Rubella
RubellaRubella
Rubella
 
tuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxtuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptx
 
national health programmes
national health programmesnational health programmes
national health programmes
 
National Leprosy Eradication Program - Dr Surendran Venkataraman
National Leprosy Eradication Program - Dr Surendran VenkataramanNational Leprosy Eradication Program - Dr Surendran Venkataraman
National Leprosy Eradication Program - Dr Surendran Venkataraman
 
EPI
EPIEPI
EPI
 

Similar to PRESENTATION ON IMMUNIZATION.pptx (20)

Lecture 07. Childhood Immunization
Lecture 07. Childhood ImmunizationLecture 07. Childhood Immunization
Lecture 07. Childhood Immunization
 
Immunization.pptx
Immunization.pptxImmunization.pptx
Immunization.pptx
 
Immunization & cold chain
Immunization & cold chainImmunization & cold chain
Immunization & cold chain
 
Immunization schedule
Immunization scheduleImmunization schedule
Immunization schedule
 
Immunization Pediatrics Presentation .pptx
Immunization Pediatrics Presentation .pptxImmunization Pediatrics Presentation .pptx
Immunization Pediatrics Presentation .pptx
 
Immunization and vaccines
Immunization and vaccinesImmunization and vaccines
Immunization and vaccines
 
Immunization (1).pptx
Immunization (1).pptxImmunization (1).pptx
Immunization (1).pptx
 
Immunization
ImmunizationImmunization
Immunization
 
Epi program (blood)
Epi program (blood)Epi program (blood)
Epi program (blood)
 
NIP-ppt.pptx
NIP-ppt.pptxNIP-ppt.pptx
NIP-ppt.pptx
 
Universal immunization programme
Universal immunization programmeUniversal immunization programme
Universal immunization programme
 
Immunization.pptx
Immunization.pptxImmunization.pptx
Immunization.pptx
 
Bacterial vaccines
Bacterial vaccinesBacterial vaccines
Bacterial vaccines
 
immunology-immunization schedule.pdf
immunology-immunization schedule.pdfimmunology-immunization schedule.pdf
immunology-immunization schedule.pdf
 
immunization dnm4 lesson 3.pptx
immunization                    dnm4 lesson 3.pptximmunization                    dnm4 lesson 3.pptx
immunization dnm4 lesson 3.pptx
 
Vaccine
VaccineVaccine
Vaccine
 
Epi seminar
Epi seminarEpi seminar
Epi seminar
 
Immunisation programme.pptx
Immunisation programme.pptxImmunisation programme.pptx
Immunisation programme.pptx
 
Vaccinations schedule in Sri Lanka
Vaccinations schedule in Sri LankaVaccinations schedule in Sri Lanka
Vaccinations schedule in Sri Lanka
 
final immunization-.pdf
final immunization-.pdffinal immunization-.pdf
final immunization-.pdf
 

Recently uploaded

Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxPooja Bhuva
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptNishitharanjan Rout
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSAnaAcapella
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsNbelano25
 
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lessonQUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lessonhttgc7rh9c
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxmarlenawright1
 
Simple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfSimple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfstareducators107
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111GangaMaiya1
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfPondicherry University
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17Celine George
 
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfUGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfNirmal Dwivedi
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Pooja Bhuva
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Pooja Bhuva
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...EADTU
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 

Recently uploaded (20)

Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Our Environment Class 10 Science Notes pdf
Our Environment Class 10 Science Notes pdfOur Environment Class 10 Science Notes pdf
Our Environment Class 10 Science Notes pdf
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf arts
 
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lessonQUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Simple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfSimple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdf
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfUGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 

PRESENTATION ON IMMUNIZATION.pptx

  • 1.
  • 2. PRESENTATION ON IMMUNIZATION PRESENTED TO: PRESENTED BY: Miss Manisha Sehgal Assistant Professor ACN Miss Muskan Thakur BS22MHNS007 MSc. Nursing 1st Year
  • 3. INTRODUCTION  Immunization is the process of artificially inducing immunity or providing protection from disease.  Immunization is the artificial means by which the state of immunity is increased.  This is the most important invention that conferred the highest benefit to children in the world.  It has helped eradicate polio and small pox for the community.
  • 4. DEFINITION  “Immunization is a process of protecting an individual from a disease through introduction of live or killed or attenuated organisms in the individual system to create immunity.”
  • 5. SIGNIFICANCE  It is most cost-effective health interventions in reduction of communicable diseases related morbidity and mortality.  It is a mass means of protecting the largest number of people from various diseases.  It gives resistance to an infectious disease by producing or augmenting the immunity.  Artificially acquired immunity is developed by immunization.
  • 6. IMMUNITY  Immunity is the security against a particular disease and nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.  Acquired immunity can be 1. Active -vaccines 2. Passive- immunoglobulins
  • 7. TYPES OF IMMUNIZATION  Active immunization:  It is the process of stimulating the body to produce antibody and other immune responses through administration of a vaccine or toxoid.  Passive Immunization:  Passive immunization is provision of temporary immunity by administration of preformed antibodies derived from humans or animals.
  • 8. PROCESS OF GENERATION OF IMMUNITY AFTER VACCINATION: 1. PRIMARY RESPONSE:  When an antigen is administered for the first time to an animal or human who has never been exposed to it, there is a latent period of induction of 3 to 10 days before antibodies appear in the blood. 2. SECONDARY (BOOSTER) RESPONSE:  The response to a booster dose differs in a number of ways from the primary response. Production of antibody is more rapid. Antibody response maintained at higher levels for a longer period of time.
  • 9. VACCINE:  Term derived from “vaccae=cow”. So, immunization agent is known as vaccine. Vaccine is a immuno- biological substance designed to produce specific protection against a given disease.
  • 11. MILSTONE IN VACCINATION:  1798 - Smallpox vaccine  1885 - Rabies vaccine  1921 - BCG  1927 - Tetanus toxoid  1954 - Salk's Polio vaccine  1957 - Sabin live oral Polio vaccine  1960 - Measles vaccine  1962 - Rubella vaccine  1980- smallpox declared eradicated from the world.
  • 12. EXPANDED PROGRAM ON IMMUNISATION:  WHO launch a global immunization program, known as Expanded Program on Immunization (EPI) in May 1974.  To protect all children of the world against six vaccine- preventable diseases, namely - diphtheria, whooping cough, tetanus, polio, tuberculosis and measles by the year 2000.  EPI was launched in India in January 1978.
  • 13. UNIVERSAL IMMUNISATION PROGRAMME:  The Indian version, the Universal Immunization Program, was launched on November 19, 1985.  The National Health Policy aimed at achieving universal immunization coverage of the eligible population by 1990.
  • 14. NATIONAL IMMUNISATION SCHEDULE: VACCINE WHEN TO GIVE DOSE ROUTE SITE FOR INFANTS BCG At birth (or as early as possible till one year of age) 0.05ml (0.1ml after 1 month till 1 year of age) I/D Left upper arm Hepatitis B At birth (or as early as possible within 24 hours) 0.5ml I/M Antero-lateral side of mid- thigh OPV-0 At birth (or as early as possible within the first 15 days) 2 drops Oral
  • 15. Cont… VACCINE WHEN TO GIVE DOSE ROUTE SITE OPV-1,2&3 At 6 weeks, 10 weeks &14 weeks (can be given till 5 years of age) 2 drops Oral Rota Virus- 1,2&3 At 6 weeks, 10 weeks &14 weeks (can be given till one year of age) 5 drops Oral Pentavalent 1,2&3 At 6 weeks, 10 weeks &14 weeks (can be given till one year of age) 0.5ml I/M Antero-lateral aspect of mid- thigh (LEFT)
  • 16. Cont… VACCINE WHEN TO GIVE DOSE ROUTE SITE IPV Two fractional doses at 6 weeks &14 weeks 0.1ml I/D Right upper arm Measles and Rubella-1 9 completed months – 12 months (given up to 5 years if not received at 9- 12month age) 0.5ml S/C Right upper arm Japanese Encephalitis-1 9 completed months -12months 0.5ml S/C Left upper arm Vitamin A (1st dose) At 9 months with measles - Rubella 1ml Oral
  • 17. Cont… FOR CHILDREN VACCINE WHEN TO GIVE DOSE ROUTE SITE DPT booster- 1 16-24 month 0.5 ml I/M Anterolateral aspect of mid- thigh Measles and Rubella-2 16-24 month 0.5 ml S/C Right upper arm OPV booster 16-24 month 2 drops Oral Japanese Encephalitis- 2 16-24 month 0.5 ml S/C Left upper arm
  • 18. Cont… VACCINE WHEN TO GIVE DOSE ROUTE SITE Vitamin A (2nd to 9th dose) 16 months with DPT/OPV booster. Then one dose every 6 month up to the age of 5 years 2 ml Oral DPT booster-2 5-6 years 0.5 ml I/M Upper Arm TT 10 years & 16 years 0.5 ml I/M Upper Arm
  • 19. Cont… FOR PREGNANT WOMEN VACCINE WHEN TO GIVE DOSE ROUTE SITE TT-1 Early in pregnancy 0.5ml I/M Upper Arm TT-2 4 weeks after TT-1 0.5ml I/M Upper Arm TT-booster If received 2 TT doses in a pregnancy within the last 3 years 0.5ml I/M Upper Arm
  • 20. IAP SCHEDULE: AGE VACCINE Birth BCG OPV (zero dose) Hep B-1 6 weeks Hep B-2 IPV-1 DPT-1 Hib-1 PCV (Pneumococcal conjugate)-1 Rotavirus-1 10 weeks Hep B-3 IPV-2 DPT-2 Hib-2 PCV-2 Rotavirus-2
  • 21. Cont… AGE VACCINE 14 weeks Hep B-4 IPV-3 DPT-3 Hib-3 PCV-3 Rotavirus-3 6 months Influenza-1 7 months Influenza-2 6-9 months TCV (Typhoid Conjugate Vaccine) 9 months MMR-1,
  • 22. Cont… AGE VACCINE 15 months MMR-2 Varicella-1 PCV booster 16-18 months IPV booster-1 DPT booster-1 Hib booster-1 18-24 months Hep A-2 Varicella-2 4-6 years IPV booster-1 DPT booster-2 MMR-3 9-14 years Tdap HPV-1&2 15-18 years HPV-1,2&3
  • 23. Passive immunization in VPD: Passive immunization is applied in following vaccine preventable disease:  Diphtheria,  Tetanus,  Hepatitis B  Rabies &  Measles.
  • 24. Vaccine Preventable diseases: According to CDC:  Chickenpox  Diphtheria  Flu  Hepatitis A  Hepatitis B  Hib  Measles  Meningococcal  Mumps  Polio  Pneumococcal  Rotavirus  Rubella  Tetanus  Whooping Cough
  • 25. DIPTHERIAANTITIOXIN: DOSE:  Prophylactic: 500 to 2000 units by S/C or I/M injection;  Therapeutic: 10,000 to 30,000 units by I/M injection or 40,000 to 100,000 units by I/V injection in 2 divided doses with an interval of 12 to 24 hours.
  • 26. MEASLES IMMUNOGLOBULIN (HUMAN): DOSE-  Recommended by WHO is 0.25 ml per kg of body weight. It should be given within 3-4 days of exposure.  The person passively immunized should be given live measles vaccine 8-12 weeks later.
  • 27. HEPATITIS B IMMUNOGLOBIN:  The recommended dose is 0.05 to 0.07 ml/kg of body weight;  two doses should be given 30 days apart.  HBIG provides short-term passive protection which lasts approximately 3 months.
  • 28. TETANUS IMMUNOGLOBIN: Dose –  250 unit for prophylaxis  3000-6000 for therapeutic
  • 29. HOW TO DESCRIBE A VACCINE: Whenever one describes a vaccine, it must be done under the following heads:  Type  Content  Dose  Time of administration  No of doses including boosters.
  • 30. Cont…  Diluent if any  Time after reconstitution  Efficacy  Storage  Side effects  contraindications
  • 31. FOR EXAMPLE: Measles vaccine:  1. Type- Freeze dried vaccine contains live attenuated virus; Stored at 2-8 degree C.  2. Dose- 0.5 ml;  3. Route- Subcutaneous.  4. Time of administration- 9 months in India.  According to W.H.O if child is malnourished,  1st dose is b/w 6-8 months;  2nd dose after 1 year.
  • 32. Cont…  5. Efficacy of Vaccine-  95%if given after one year.  At nine months -85%  6. Duration of immunity– Lifelong.  7. It is freeze dried vaccine  8. Has to be reconstituted with distilled water  9. Reconstituted vaccine must be used as early as possible  10. It has shell life for 2 years  11. Must be stored between 2-8 degree centigrade
  • 33. Recent W.H.O. recommendation –  1st dose of measles at 9 months.  2nd dose of M.M.R. – 15 months.  This vaccine may also be given to contacting person.
  • 34. Complications of vaccine:  1. Fever  2. Rash  4. T.S.S
  • 35. Contraindications of Measles vaccine:  1. Impaired cell-mediated immunity.  2. Convulsions.  3. Patient on steroids.  4. Pregnancy  5. Active T.B.  6. Acute infectious disease.  7. Generalized allergy.
  • 36. How to calculate vaccine requirement: There are two ways to calculate vaccine requirement—  1. Based on real number of beneficiaries in community.  2. Based on, Birth Rate and IMR.
  • 37. Based on real number of beneficiaries in community.  Count the total number of beneficiaries, like infant, pregnant mother etc.  Multiply it with total number of doses of vaccine to be given.  Now multiply it with wastage factor for different vaccines  E.g.- If there are 100 infants. Number of doses of BCG require will be:  100× 1 × 1.33= 133 doses  Since vial of BCG come in doses of 10.  So needed vial will be= 133/10= 13.3 i.e., 14
  • 38. RESEARCH ARTICLE  Telemedicine in the National Immunization Program (Brazil): A promising tool  The objective of this study was to evaluate the acceptance and impact of telemedicine at a Reference Center for Special Immunobiological (CRIE). Patients aged 18 years or older who had a medical referral to CRIE and agreed to have a telemedicine consultation were included. From April 2021 to February 2022, 702 telemedicine consultation were conducted. Over 3,380 vaccines were prescribed via telemedicine. Of all the participants who answered the satisfaction questionnaire, 99.8% stated that they would recommend the service to other people.
  • 39. SUMMARY  In this topic I have explained about introduction, definition & significance of immunization. Immunity and types of immunity and immunization also explained. Process of generation of immunity after vaccination, vaccine & types of vaccine, milestones in immunization, expanded program on immunization, universal immunization program, national and IAP immunization schedule also discussed. Passive immunization in VPD & how to describe a vaccine.
  • 40. CONCLUSION  Vaccines for contagious diseases have strong spillover effects, given that immunization interrupts the disease transmission process and reduces the likelihood that an infection will harm others. Immunization helps protect future generations by eradicating diseases.  It is the process of the production of antibodies against diseases. These are mainly used against bacterial and viral diseases in both humans and cattle.
  • 41.
  • 42. RECAPITULATION  Define immunization?  What is immunity?  What are the types of immunization?  Explain about national immunization program?  What is passive immunization in VPD?  How to describe a vaccine?
  • 43. MCQ-  1. Name the vaccine which was first discovered in the world  a) Rabies  b) Plaque  c) Small pox  d) Chicken pox
  • 44. Cont…  2. In which year small pox vaccine was discovered  a) 1798  b) 1898  c) 1998  d) 1800
  • 45. Cont…  3. The dose of immunoglobulin in the prevention of measles is  a) 1 ml/kg  b) 1.5ml/kg  c) 0.5ml/kg  d) 0.25ml/kg
  • 46. Cont… 4. Universal Immunization programme started in India a. 1974 b. 1978 c. 1985 d. 1995
  • 47. Cont…  5. Sabin is type of vaccine a. Live b. Killed c. Toxoid d. Killed
  • 48. Cont…  6. BCG vaccine must be used after dilution/ reconstitution within a. 24 hours b. 12 hours c. 6 hours d. 4 hours
  • 49. ASSIGNMENT  Make assignment on immunization schedule.